A combination of genetic suppressor elements produces resistance to drugs inhibiting DNA replication

Somat Cell Mol Genet. 1999 Jan;25(1):9-26. doi: 10.1023/b:scam.0000007136.49230.b3.

Abstract

Many anticancer drugs inhibit DNA replication. To investigate the mechanism of permanent growth inhibition after transient arrest of DNA replication, we selected genetic suppressor elements (GSEs) conferring resistance to replication inhibitor Aphidicolin. Starting from a retroviral expression library carrying normalized fragments of human cell cDNA, we isolated four GSEs which, when introduced as a combination, produced resistance to Aphidicolin, doxorubicin and hydroxyurea in HT1080 fibrosarcoma cells. The four GSEs were derived from ORFX bromodomain protein gene, WIZ zinc finger protein gene, the gene for subunit 3 of cytochrome c oxidase, and the gene corresponding to an EST with no known function. A cell line carrying all four GSEs showed a weaker induction of the senescence-like phenotype after treatment with Aphidicolin or doxorubicin; the resistance of this cell line was not associated with decreased doxorubicin accumulation. These results indicate that combined effects of GSEs derived from these four genes increase cellular resistance to replication-inhibiting drugs, possibly by inhibiting drug-induced senescence.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Aphidicolin / pharmacology*
  • Base Sequence
  • DNA Replication / drug effects*
  • DNA, Antisense / genetics
  • DNA, Complementary / genetics
  • DNA, Complementary / isolation & purification
  • Doxorubicin / pharmacology
  • Drug Resistance / genetics
  • Gene Library
  • Genes, Suppressor*
  • HeLa Cells
  • Humans
  • Hydroxyurea / pharmacology
  • Molecular Sequence Data
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents
  • DNA, Antisense
  • DNA, Complementary
  • Aphidicolin
  • Doxorubicin
  • Hydroxyurea